PMID- 27230861 OWN - NLM STAT- MEDLINE DCOM- 20170307 LR - 20220411 IS - 1423-0348 (Electronic) IS - 0033-3190 (Linking) VI - 85 IP - 4 DP - 2016 TI - Group- and Home-Based Cognitive Intervention for Patients with Mild Cognitive Impairment: A Randomized Controlled Trial. PG - 198-207 LID - 10.1159/000442261 [doi] AB - BACKGROUND: We examined the efficacy of group-based cognitive intervention (GCI) and home-based cognitive intervention (HCI) in amnestic mild cognitive impairment (aMCI) and intervention effects on serum brain-derived neurotrophic factor (BDNF). METHODS: In this randomized and rater-blinded trial, 293 patients with aMCI from 18 nationwide hospitals were randomized: 96 to the GCI group, 98 to the HCI group and 99 to the control group. For 12 weeks, subjects receiving GCI participated twice per week in group sessions led by trained instructors, and those receiving HCI completed homework materials 5 days per week. They were assessed at baseline, postintervention (PI) and at the 6-month follow-up after the intervention. The primary endpoint was the change from baseline to PI in the modified Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-Cog). RESULTS: In comparison to the controls (a 0.8-point decrease), the subjects receiving GCI (a 2.3-point decrease, p = 0.01) or HCI (a 2.5-point decrease, p = 0.02) showed significant improvements in the modified ADAS-Cog at PI, respectively. By the 6-month follow-up, those receiving GCI or HCI had better scores in the modified ADAS-Cog than the controls. The changes in BDNF levels significantly correlated with the changes in the modified ADAS-Cog in the GCI (r = -0.29, p = 0.02 at PI) and HCI (r = -0.27, p = 0.03 at 6-month follow-up) groups, respectively. CONCLUSIONS: The GCI and HCI resulted in cognitive improvements in aMCI. An enhanced brain plasticity may be a component of the mechanism underpinning the cognitive improvements associated with the cognitive interventions. CI - (c) 2016 The Author(s) Published by S. Karger AG, Basel. FAU - Jeong, Jee Hyang AU - Jeong JH AD - Department of Neurology, Ewha Womans University Mokdong Hospital, Ewha Womans University School of Medicine, Seoul, South Korea. FAU - Na, Hae Ri AU - Na HR FAU - Choi, Seong Hye AU - Choi SH FAU - Kim, Jungeun AU - Kim J FAU - Na, Duk L AU - Na DL FAU - Seo, Sang Won AU - Seo SW FAU - Chin, Juhee AU - Chin J FAU - Park, Sun Ah AU - Park SA FAU - Kim, Eun-Joo AU - Kim EJ FAU - Han, Hyun Jeong AU - Han HJ FAU - Han, Seol-Heui AU - Han SH FAU - Yoon, Soo Jin AU - Yoon SJ FAU - Lee, Jae-Hong AU - Lee JH FAU - Park, Kyung Won AU - Park KW FAU - Moon, So Young AU - Moon SY FAU - Park, Moon Ho AU - Park MH FAU - Choi, Mun Seong AU - Choi MS FAU - Han, Il-Woo AU - Han IW FAU - Lee, Jun Hong AU - Lee JH FAU - Lee, Jung Seok AU - Lee JS FAU - Shim, Yong S AU - Shim YS FAU - Kim, Jeong Yeon AU - Kim JY LA - eng PT - Journal Article PT - Multicenter Study PT - Randomized Controlled Trial DEP - 20160527 PL - Switzerland TA - Psychother Psychosom JT - Psychotherapy and psychosomatics JID - 0024046 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 7171WSG8A2 (BDNF protein, human) SB - IM MH - Aged MH - Aged, 80 and over MH - Amnesia/*therapy MH - Brain-Derived Neurotrophic Factor/*blood MH - Cognition MH - Cognitive Behavioral Therapy/*methods/standards MH - Cognitive Dysfunction/*therapy MH - Female MH - Humans MH - Male MH - Middle Aged MH - Neuropsychological Tests MH - Psychiatric Status Rating Scales MH - Psychotherapy, Group/*methods MH - Republic of Korea MH - Self Care/*methods MH - Single-Blind Method MH - Treatment Outcome EDAT- 2016/05/28 06:00 MHDA- 2017/03/08 06:00 CRDT- 2016/05/28 06:00 PHST- 2015/05/15 00:00 [received] PHST- 2015/11/06 00:00 [accepted] PHST- 2016/05/28 06:00 [entrez] PHST- 2016/05/28 06:00 [pubmed] PHST- 2017/03/08 06:00 [medline] AID - 000442261 [pii] AID - 10.1159/000442261 [doi] PST - ppublish SO - Psychother Psychosom. 2016;85(4):198-207. doi: 10.1159/000442261. Epub 2016 May 27.